GGrantIndex
← Search

CORE--TISSUE CULTURE

$0P30FY2002CANIH

University Of Arizona, Tucson AZ

Investigators

Linked publications, trials & patents

Paper 39631050Paper 39622842Paper 39612086Paper 39361227Paper 39312766Paper 39151774Paper 39100646Paper 39075233Paper 38875929Paper 38858600Paper 38826434Paper 38804255Paper 38769192Paper 38759377Paper 38729260Paper 38719743Paper 38715255Paper 38687603Paper 38658768Paper 38639990Paper 38613866Paper 38612480Paper 38474232Paper 38464045Paper 38453918Paper 38386696Paper 38386396Paper 38328594Paper 38313301Paper 38309054Paper 38291312Paper 38215755Paper 38203706Paper 38199366Paper 38164625Paper 38164604Paper 38097734Paper 38097593Paper 38096366Trial NCT07214506Trial NCT06009926Trial NCT05699603Trial NCT05237960Trial NCT05121051Trial NCT04530552Trial NCT03708055Trial NCT03602066Trial NCT03601507Trial NCT03578432Trial NCT03422536Trial NCT03402230Trial NCT03376971Trial NCT03365895Trial NCT03196180Trial NCT02581137Trial NCT02568566Trial NCT02348203Trial NCT02326805Trial NCT02123849Trial NCT01686165Trial NCT01433913Trial NCT01394211Trial NCT01385280Trial NCT01370889Trial NCT01288261Trial NCT01172028Trial NCT01097304Trial NCT01077453Trial NCT00980395Trial NCT00978718Trial NCT00900432Trial NCT00900341Trial NCT00898703Trial NCT00896935Trial NCT00892268Trial NCT00841204Trial NCT00752739Trial NCT00732498Trial NCT00721877Trial NCT00702299Trial NCT00701857Trial NCT00699907Trial NCT00619060Trial NCT00608634Trial NCT00601640Trial NCT00410618Trial NCT00373022Trial NCT00363805Trial NCT00303823Trial NCT00245024Trial NCT00091325Trial NCT00078897Trial NCT00003307Trial NCT00003082Patent 9486545Patent 9435812Patent 9415110Patent 9262824Patent 5650489Patent 5510240

Abstract

The goal of the Tissue Culture Shared Service is to enhance the quality of laboratory research at the Arizona Cancer Center by providing specialized cell culture services to Cancer Center investigators. The objectives of the service include providing: 1. Cell lines for addressing cancer-related research questions; 2. Cost-effective quality control measures necessary for excellent science with in vitro cancer models; 3. Reagents for cell culture that are not commercially available or are more cost-effective when obtained through the service; 4. Consultative expertise in tissue culture; 5. Assistance to the genetically modified nice shared service in establishing knock-mice. More than 250 human tumor-derived cell lines have been established by the Tissue Culture Shared Service. Cancer Center investigators have used these in cytogenetic and molecular studies to identify genetic changes in cancer and in pharmacological studies to evaluate new chemotherapeutic agents. Cell lines from this bank also have been provided to the NCI and ATCC. This service provides cost effect mycoplasma screening of cell lines to encourage regular testing. This helps ensure that results obtained by Center investigators using in vitro models are not artifacts of mycoplasma infection. The service conducts quality assurance/quality control testing of fetal bovine serum lots. The effectiveness of different lots at supporting cell line growth relative to cost is assessed and large lot prices are then negotiated at a considerable savings to investigators. By maintaining embryonic stem cell culture for the Genetically Modified Mice Shared Service, it is anticipated that the expertise of the personnel in the Tissue Culture Shared Service will be key to the successful development of knock-out mouse models at the Arizona Cancer Center.

View original record on NIH RePORTER →